SCHEMBL25826992

SCHEMBL25826992

Bc1cc([C@]2(C#N)OC(C(B)(B)O)[C@@H](OC(=O)[C@@H](N)C(C)C)[C@H]2O)n2ncnc(N)c12

nearest known ligand 0.00

⚠ Novel chemotype — no close known analogue (best Tanimoto < 0.3). Unexplored chemical space relative to ChEMBL.

Similar compounds — the chemically nearest patent molecules

Nearest neighbours by Morgan-fingerprint cosine across the patent-compound collection, with each neighbour's top predicted target and the predicted targets it shares with this molecule.

Compoundsimilaritytop predictedshared targets
SCHEMBL25826988 0.93 PIK3CD (0.30) —
SCHEMBL25826900 0.87 TMPRSS2 (0.36) —
SCHEMBL25826921 0.87 TMPRSS2 (0.36) —
SCHEMBL25827006 0.85 PIK3CD (0.31) —
SCHEMBL25826846 0.81 TMPRSS2 (0.32) —
SCHEMBL25826905 0.80 TMPRSS2 (0.37) —
SCHEMBL25826990 0.79 PIK3CD (0.32) —
SCHEMBL25826889 0.79 TMPRSS2 (0.37) —
SCHEMBL25826910 0.79 TMPRSS2 (0.37) —
SCHEMBL25826531 0.79 TMPRSS2 (0.32) —

Similarity is cosine over the 2,048-bit Morgan fingerprint (≈ Tanimoto). Identical fingerprints score 1.00.

Patent provenance — the patents this molecule appears in, and who filed them

Claimed or disclosed in 1 patent. claimed = in the patent's claims; disclosed = body only.

PatentTitleAssigneePublishedPriorityFilingCountryStatus
US-20230219993-A1 ANTIVIRAL APPLICATION OF NUCLEOSIDE ANALOG OR COMBINATION FORMULATION CONTAINING NUCLEOSIDE ANALOG VIGONVITA LIFE SCIENCES CO., LTD. (CN) 2023-07-13 — — US disclosed
Send feedback